ATH 33.3% 0.4¢ alterity therapeutics limited

I am in ... great expectations on this one., page-6

  1. 7,425 Posts.
    lightbulb Created with Sketch. 125
    Yes it will. When the PBT2 is approved as treatment for Huntington.....or maybe sooner when they start progressing it towards that outcome.....PBT2 for HD will be first on the market and it will make Prana famous (2017?)....progress of PBT2 for AD is further away .....I can't see anything happening in 2016 in that space.....happy to be proven wrong....
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.